SCHEMBL7701897

SCHEMBL7701897

Cc1ccc(C(=O)Nc2ccc(-c3oc(-c4ccccc4)nc3C(=O)O)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
GAA P10253 2/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
HTT P42858 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPT P10636 6/20 0.53
RAB9A P51151 4/20 0.53
NPC1 O15118 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 2/20 0.50
RXFP1 Q9HBX9 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
FABP1 P07148 1/20 0.49
P2RY14 Q15391 1/20 0.49
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695319 0.89 MAPT (0.57) KDM4EGAAHPGDHTTTDP1
SCHEMBL7701088 0.88 MAPT (0.53) KDM4EGAAMAPTSMN1; SMN2RXFP1
SCHEMBL7697940 0.88 MAPT (0.57) KDM4EGAALMNAHPGDHTT
SCHEMBL7704976 0.88 MAPT (0.61) KDM4EGAAHPGDMAPTRAB9A
SCHEMBL3128951 0.87 IKBKB (0.54) KDM4EGAALMNAHPGDHTT
SCHEMBL7700032 0.86 NPC1 (0.55) KDM4EGAALMNAHPGDHTT
SCHEMBL7703322 0.85 KDM4E (0.72) KDM4EGAAHPGDTDP1MAPT
SCHEMBL7696209 0.84 KDM4E (0.55) KDM4EGAALMNAHPGDHTT
SCHEMBL7693588 0.83 KDM4E (0.65) KDM4EGAALMNAHPGDTDP1
SCHEMBL7699504 0.83 MAPT (0.55) KDM4ELMNAHPGDHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002064558-A2 OXAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYTOKINE INHIBITORS SANKYO COMPANY, LIMITED (JP) 2002-08-22 WO disclosed